Tocilizumab as a promising agent against COVID-19: Issues and challenges

Detalles Bibliográficos
Autores principales: Dastan, Farzaneh, Tabarsi, Payam, Abedini, Atefeh, Saffaei, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Letter to Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548894/
https://www.ncbi.nlm.nih.gov/pubmed/34759997
http://dx.doi.org/10.4103/jrms.JRMS_524_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548894/
https://www.ncbi.nlm.nih.gov/pubmed/34759997
http://dx.doi.org/10.4103/jrms.JRMS_524_20

Ejemplares similares